Page last updated: 2024-10-28

ethidium and Myasthenia Gravis

ethidium has been researched along with Myasthenia Gravis in 1 studies

Ethidium: A trypanocidal agent and possible antiviral agent that is widely used in experimental cell biology and biochemistry. Ethidium has several experimentally useful properties including binding to nucleic acids, noncompetitive inhibition of nicotinic acetylcholine receptors, and fluorescence among others. It is most commonly used as the bromide.
ethidium : The fluorescent compound widely used in experimental cell biology and biochemistry to reveal double-stranded DNA and RNA.

Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakthivel, P1
Wang, X1
Gharizadeh, B1
Giscombe, R1
Pirskanen, R1
Nyren, P1
Lefvert, AK1

Other Studies

1 other study available for ethidium and Myasthenia Gravis

ArticleYear
Single-nucleotide polymorphisms in the B7H3 gene are not associated with human autoimmune myasthenia gravis.
    Journal of genetics, 2006, Volume: 85, Issue:3

    Topics: Alleles; Antigens, CD; B7 Antigens; Case-Control Studies; Chi-Square Distribution; Electrophoresis,

2006